CureVac Files Patent Infringement Suit Against BioNTech (1)

CureVac NV is suing BioNTech SE, arguing its work in messenger RNA technology was used in development of the fellow German biopharmaceutical company’s Covid-19 vaccine.

CureVac is “seeking fair compensation” for infringement of CureVac’s intellectual property rights, the company said in a statement Tuesday. It’s not seeking an injunction or legal action that “impedes the production, sale or distribution” of the vaccine, it added. The lawsuit has been filed in Dusseldorf against BioNTech and two of its subsidiaries.

BioNTech developed its Covid shot in partnership with Pfizer Inc. and sales at both companies have soared as the vaccine has ...